| |
|
|
|
Acasti Pharma Inc.  
|
|
0.5672 0.004 (0.01%) |
09-20 15:59 |
|
Open: |
0.5629 |
Pre close: |
0.5629 |
Target:
|
0.71
|
|
High: |
0.57 |
Low: |
0.525 |
Resistance:
|
0.61
0.71
|
|
Volume: |
84,755 |
Market Cap: |
21M |
Support:
|
0.50
0.43
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.55
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
0.54 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
0.61  |
Stochastic Oscillator |
%K(14,3):
|
52.78 |
|
MA(250): |
0.96 |
%D(3): |
47.72 |
|
Average Volume(K) |
3-Month: |
18014
|
52-Week |
High:
|
3.36 |
|
10-Days: |
11256 |
Low: |
0.43 |
|
RSI |
RSI(14):
|
53.96 |
Change(%): |
-57.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-192.3 |
Shares Out. (M) |
36.68 |
|
EPS Est. Current Year |
-0.730 |
Return on Assets (ttm) |
-104.1 |
Shares Float (M) |
36.68 |
|
EPS Est. Next Year |
-0.770 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.90 |
|
Forward EPS |
-0.351 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
520 |
|
Book Value (p.s.) |
3.450 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.41 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-1.66 |
|
|
|
|
|
|
